Allan Goldstein

Insider Reports History

Signature
/s/ Andrew Nick as attorney-in-fact for Allan Goldstein pursuant to a power of attorney filed previously.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Allan Goldstein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENERX BIOPHARMACEUTICALS INC Director Common Stock 1.51M May 17, 2022 Direct
REGENERX BIOPHARMACEUTICALS INC Director Stock Option (Right to Buy) 480K May 17, 2022 Direct
REGENERX BIOPHARMACEUTICALS INC Director Convertible Promissory Note (right to buy) 10.4K May 17, 2022 Direct
REGENERX BIOPHARMACEUTICALS INC Director Common Stock Warrant (right to buy) 0 May 17, 2022 Direct
REGENERX BIOPHARMACEUTICALS INC Director Series A Common Stock Warrant (right to buy) 0 May 17, 2022 Direct
REGENERX BIOPHARMACEUTICALS INC Director Series B Common Stock Warrant (right to buy) 0 May 17, 2022 Direct

Insider Reports Filed by Allan Goldstein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGRX REGENERX BIOPHARMACEUTICALS INC May 17, 2022 1 $0 4 May 19, 2022 Director
RGRX REGENERX BIOPHARMACEUTICALS INC Dec 8, 2021 1 $0 4 Mar 2, 2022 Director
RGRX REGENERX BIOPHARMACEUTICALS INC Aug 2, 2021 1 $0 4 Aug 4, 2021 Director
RGRX REGENERX BIOPHARMACEUTICALS INC Jun 30, 2021 3 $25K 4 Jul 6, 2021 Director